[1]王艳霞.中药灌肠对尿毒症血液透析患者便秘、食欲减退及呕吐等不良反应的影响[J].医学信息,2022,35(17):88-90,94.[doi:10.3969/j.issn.1006-1959.2022.17.023]
 WANG Yan-xia.Effect of Traditional Chinese Herb Enema on Adverse Reactions of Constipation,Loss of Appetite and Vomiting in Uremic Hemodialysis Patients[J].Journal of Medical Information,2022,35(17):88-90,94.[doi:10.3969/j.issn.1006-1959.2022.17.023]
点击复制

中药灌肠对尿毒症血液透析患者便秘、食欲减退及呕吐等不良反应的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年17期
页码:
88-90,94
栏目:
论著
出版日期:
2022-09-01

文章信息/Info

Title:
Effect of Traditional Chinese Herb Enema on Adverse Reactions of Constipation,Loss of Appetite and Vomiting in Uremic Hemodialysis Patients
文章编号:
1006-1959(2022)17-0088-04
作者:
王艳霞
(天津市北辰区中医医院血透科,天津 300400)
Author(s):
WANG Yan-xia
(Department of Hemodialysis,Beichen District Hospital of Traditional Chinese Medicine,Tianjin 300400,China)
关键词:
尿毒症血液透析中药灌肠便秘食欲减退呕吐
Keywords:
UremiaHemodialysisTraditional Chinese medicine enemaConstipationLoss of appetiteVomiting
分类号:
R692.5
DOI:
10.3969/j.issn.1006-1959.2022.17.023
文献标志码:
A
摘要:
目的 研究中药灌肠对尿毒症血液透析患者便秘、食欲减退及呕吐等不良反应的影响。方法 选取2019年6月-2021年6月于天津市北辰区中医医院接受血液透析治疗的80例尿毒症患者,按照随机数字表法分为对照组和观察组,各40例。对照组行常规血液透析治疗,观察组采用中药灌肠联合血液透析治疗,比较两组临床疗效、血清生化指标[血肌酐(SCr)、尿素氮(BUN)、内生肌酐清除率(CCr)]、透析充分性[蛋白分解率(PCR)、尿素清除指数Kt/V值、平均尿素氮浓度(TACurea)]、氧化应激指标[血浆丙二醛(P-MDA)、超氧化物歧化酶(P-SOD)、过氧化氢酶(P-CAT)]、不良反应发生情况(便秘、食欲减退、呕吐)。结果 观察组治疗有效率高于对照组,差异有统计学意义(P<0.05);两组治疗后SCr、BUN水平下降,CCr水平升高,且观察组SCr、BUN水平低于对照组,CCr水平高于对照组,差异有统计学意义(P<0.05);观察组PCR、TACurea低于对照组,Kt/V值高于对照组,差异有统计学意义(P<0.05);对照组治疗后P-MDA高于治疗前及观察组,P-SOD、P-CAT低于治疗前及观察组,差异有统计学意义(P<0.05);观察组治疗前后P-MDA、P-SOD、P-CAT水平比较,差异无统计学意义(P>0.05);观察组便秘、食欲减退、呕吐发生率低于对照组,差异有统计学意义(P<0.05)。结论 中药灌肠可增强血液透析效果,保证血透充分性,同时抑制氧化应激反应亢进,降低便秘、食欲减退及呕吐等不良反应的发生风险。
Abstract:
Objective To study the effect of traditional Chinese medicine enema on adverse reactions such as constipation, loss of appetite and vomiting in uremic hemodialysis patients.Methods A total of 80 patients with uremia who received hemodialysis in Tianjin Beichen District Hospital of Traditional Chinese Medicine from June 2019 to June 2021 were selected and divided into control group and observation group according to the random number table method, with 40 cases in each group. The control group was treated with routine hemodialysis, and the observation group was treated with traditional Chinese medicine enema combined with hemodialysis. The clinical efficacy, serum biochemical indexes [serum creatinine (SCr), urea nitrogen (BUN), endogenous creatinine clearance rate (CCr)], dialysis adequacy [protein decomposition rate (PCR), urea clearance index Kt/V value, average urea nitrogen concentration (TACurea)], oxidative stress indexes [plasma malondialdehyde (P-MDA), superoxide dismutase (P-SOD), catalase (P-CAT) ], adverse reactions (constipation, loss of appetite, vomiting) were compared between the two groups.Results The effective rate of treatment in the observation group was higher than that in the control group, and the difference was statistically significant (P<0.05). After treatment, the levels of SCr and BUN in the two groups decreased, and the level of CCr increased,while the levels of SCr and BUN in the observation group were lower than those in the control group, and the level of CCr was higher than that in the control group,the difference was statistically significant (P<0.05). The PCR and TACurea in the observation group were lower than those in the control group, and the Kt/V value was higher than that in the control group, and the difference was statistically significant (P<0.05). After treatment, P-MDA in the control group was higher than that before treatment and in the observation group, P-SOD and P-CAT were lower than those before treatment and in the observation group, and the differences were statistically significant (P<0.05). There was no significant difference in the levels of P-MDA, P-SOD and P-CAT before and after treatment in the observation group (P>0.05). The incidence of constipation, loss of appetite and vomiting in the observation group was lower than that in the control group, and the difference was statistically significant (P<0.05).Conclusion Traditional Chinese medicine enema can enhance the effect of hemodialysis, ensure the adequacy of hemodialysis, inhibit the hyperactivity of oxidative stress, and reduce the risk of adverse reactions such as constipation, loss of appetite and vomiting.

参考文献/References:

[1]Zhang ZH,Mao JR,Chen H,et al.Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites[J].Clinical Biochemistry,2017,50(18):1078-1086.[2]潘金欣,陈霞,崔莹莹,等.中药灌肠联合血液透析对慢性肾衰竭患者炎症介质水平及肾功能的影响[J].实用中西医结合临床,2021,21(12):22-23,95.[3]项继静.维持性血液透析合并慢性便秘患者中医证候分布特点研究[J].中西医结合研究,2021,13(1):19-23.[4]Snauwaert E,Holvoet E,Biesen WV,et al.Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population[J].Toxins,2019,11(4):235.[5]马俊杰,魏善斋.肺肠同治指导下中医药灌肠干预持续性血液透析尿毒症皮肤瘙痒研究[J].世界科学技术-中医药现代化,2020,22(1):164-168.[6]胥小鹏,冯亚男.中药联合血液透析滤过治疗尿毒症难治性高血压的可行性研究[J].中国农村卫生,2019,11(15):48-49.[7]何银欢.通腑泄浊法中药灌肠联合血液透析对慢性肾功能衰竭尿毒症期患者的治疗效果[J].慢性病学杂志,2020,21(1):83-86.[8]陈然,曹之娣,陈建晓,等.增液承气汤治疗维持性血液透析患者慢性便秘30例[J].浙江中医杂志,2021,56(6):427-428.[9]胡总丽,王向伟,张倩倩.血液透析结合中药灌肠治疗慢性肾功能不全临床观察[J].社区医学杂志,2019,17(11):660-663.[10]周霜,何桂顺,尹冬彩,等.中药灌肠配合血液透析治疗急性肾衰竭40例[J].中国中医药科技,2019,26(3):443-444.[11]段丽娟,付利梅.益元活血排毒方保留灌肠对规律透析患者生存质量的影响[J].河北中医药学报,2019,34(1):28-30.[12]魏玲,王亿平,茅燕萍,等.结肠透析联合中药保留灌肠对慢性肾衰湿热证患者微炎症指标的影响[J].河北中医药学报,2018,33(4):20-22.[13]冷伟,刘春莹,马莉莎,等.涤毒灌肠方对慢性肾衰竭患者肠源性尿毒症毒素的影响分析[J].现代生物医学进展,2018,18(22):4265-4268,4329.[14]刘正翠,游励红,肖红波,等.维持性血液透析患者症状群的确立及其与生活质量的相关性研究[J].中国血液净化,2018,17(11):748-752.[15]张先芹,谢小行.中医整体排毒疗法在尿毒症治疗中的运用[J].湖北中医杂志,2018,40(9):12-14.[16]冯冰,王乾,王园园.通腑泄浊法中药灌肠联合血液透析治疗慢性肾功能衰竭的临床观察[J].中华中医药学刊,2019,37(1):180-182.[17]吴禹池,张上鹏,尹自长,等.血液透析患者便秘情况及其相关因素分析[J].中国现代医学杂志,2018,28(12):58-62.[18]朱彩辉,杨莹,范亚楠.中药灌肠联合血液透析治疗慢性肾衰竭疗效观察[J].四川医学,2017,38(6):671-674.[19]葛玉英,程亚菲,王秋妹.中药灌肠结合血液透析治疗慢性肾功能不全疗效及对血清CRP、脂联素水平影响[J].中华中医药学刊,2016,34(12):3025-3027.[20]周培一.中药灌肠结合血液透析治疗慢性肾功能不全疗效观察[J].现代中西医结合杂志,2016,25(13):1442-1444.[21]许朕,张露,马艳艳,等.维持性血液透析患者氧化应激水平多因素分析[J].国际泌尿系统杂志,2017,37(1):18-23.[22]章平.中医排毒疗法对尿毒症血液透析患者治疗效果的影响[J].湖北中医杂志,2015,37(1):5-6.[23]秦雪娟,卢昭,李红帅.中药保留灌肠联合血液透析治疗终末期糖尿病肾病临床研究[J].新中医,2021,53(17):97-101.

相似文献/References:

[1]肖一红.组合型人工肾技术预防血液透析中低血压的效果观察[J].医学信息,2018,31(03):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
 XIAO Yi-hong.Effect of Combined Artificial Renal Technique in Preventing Hypotension in Hemodialysis[J].Journal of Medical Information,2018,31(17):185.[doi:10.3969/j.issn.1006-1959.2018.03.070]
[2]邹 鑫,刘秀娟,余燕燕.血液透析对MHD患者血清FGF-23水平与 钙磷代谢的影响[J].医学信息,2018,31(09):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
 ZOU Xin,LIU Xiu-juan,YU Yan-yan.Effect of Hemodialysis on Serum FGF-23 Level and Calcium and Phosphorus Metabolism in MHD Patients[J].Journal of Medical Information,2018,31(17):119.[doi:10.3969/j.issn.1006-1959.2018.09.036]
[3]王允彦.西那卡塞对维持性血液透析继发性甲状旁腺功能亢进患者FGF-23的影响[J].医学信息,2018,31(13):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
 WANG Yun-yan.Effect of Cinacalcet on FGF-23 in Patients with Secondary Hyperparathyroidism during Maintenance Hemodialysis[J].Journal of Medical Information,2018,31(17):88.[doi:10.3969/j.issn.1006-1959.2018.13.025]
[4]方海东,李 荣.血液透析滤过联合血液透析治疗慢性肾功能衰竭的效果观察[J].医学信息,2019,32(02):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
 FANG Hai-dong,LI Rong.Effect of Hemodiafiltration Combined with Hemodialysis on Chronic Renal Failure[J].Journal of Medical Information,2019,32(17):129.[doi:10.3969/j.issn.1006-1959.2019.02.037]
[5]蒋红利,刘 华,史珂慧,等.陕西省县级医院透析室建设项目培训效果评价[J].医学信息,2018,31(19):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
 JIANG Hong-li,LIU Hua,SHI Ke-hui,et al.Evaluation on Training Effect of Dialysis Room Construction Project in County Hospitals in Shaanxi Province[J].Journal of Medical Information,2018,31(17):120.[doi:10.3969/j.issn.1006-1959.2018.19.036]
[6]王苏杭,董春锋.维持性血液透析患者应用palindrome导管置换失permcath导管分析[J].医学信息,2019,32(06):117.[doi:10.3969/j.issn.1006-1959.2019.06.036]
 WANG Su-hang,DONG Chun-feng.Analysis of Permcath Catheters in Patients with Maintenance Hemodialysis Using Palindrome Catheter Replacement[J].Journal of Medical Information,2019,32(17):117.[doi:10.3969/j.issn.1006-1959.2019.06.036]
[7]张民霞.血液灌流联合血液透析治疗肾功能衰竭难治性高血压的效果[J].医学信息,2019,32(15):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
 ZHANG Min-xia.Effect of Hemoperfusion Combined with Hemodialysis on Refractory Hypertension with Renal Failure[J].Journal of Medical Information,2019,32(17):109.[doi:10.3969/j.issn.1006-1959.2019.15.035]
[8]谢 华,周毅峰,甘晓庆,等.血液透析专用中心静脉导管封管液的研究[J].医学信息,2019,32(18):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
 XIE Hua,ZHOU Yi-feng,GAN Xiao-qing,et al.Research on Central Venous Catheter Sealing Fluid for Hemodialysis[J].Journal of Medical Information,2019,32(17):48.[doi:10.3969/j.issn.1006-1959.2019.18.016]
[9]喻学娜.协同护理对终末期肾脏病血液透析患者自我护理能力及治疗依从性的影响[J].医学信息,2019,32(20):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
 YU Xue-na.Effect of Collaborative Nursing on Self-care Ability and Treatment Compliance of Hemodialysis Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(17):183.[doi:10.3969/j.issn.1006-1959.2019.20.059]
[10]魏昌林.血液透析联合血液灌流在终末期肾病患者治疗中的应用[J].医学信息,2019,32(13):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
 WEI Chang-lin.Application of Hemodialysis Combined with Blood Perfusion in the Treatment of Patients with End-stage Renal Disease[J].Journal of Medical Information,2019,32(17):109.[doi:10.3969/j.issn.1006-1959.2019.13.032]
[11]钟瑜辉.血液透析联合血液灌流治疗尿毒症的效果[J].医学信息,2019,32(21):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]
 ZHONG Yu-hui.Effect of Hemodialysis Combined with Blood Perfusion on Uremia[J].Journal of Medical Information,2019,32(17):108.[doi:10.3969/j.issn.1006-1959.2019.21.034]
[12]程 坤.醋酸钙联合碳酸镧治疗尿毒症血液透析高磷血症的疗效[J].医学信息,2021,34(18):155.[doi:10.3969/j.issn.1006-1959.2021.18.042]
 CHENG Kun.Efficacy of Calcium Acetate Combined with Lanthanum Carbonate in the Treatment of Uremic Hemodialysis Hyperphosphatemia[J].Journal of Medical Information,2021,34(17):155.[doi:10.3969/j.issn.1006-1959.2021.18.042]
[13]徐娇瑾.健康教育导向的循证护理干预对尿毒症血液透析患者血管通路依从性和生活质量的影响[J].医学信息,2022,35(01):190.[doi:10.3969/j.issn.1006-1959.2022.01.049]
 XU Jiao-jin.Effect of Health Education-oriented Evidence-based Nursing Intervention on Vascular Pathway Compliance and Quality of Life in Uremic Hemodialysis Patients[J].Journal of Medical Information,2022,35(17):190.[doi:10.3969/j.issn.1006-1959.2022.01.049]

更新日期/Last Update: 1900-01-01